Usefulness of Natriuretic Peptide Testing for Long-Term Risk Assessment Following Acute Ischemic Stroke

American Journal of Cardiology

Volumn 104, Issue 2, 2009, Pages 287-291

  Jensen, Jesper K ^a   Atar, Dan ^b   Kristensen, Søren R ^c   Mickley, Hans ^a   Januzzi Jr , James L ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SURVIVAL RATE;

ACUTE DISEASE; AGED; AREA UNDER CURVE; BRAIN ISCHEMIA; CONFIDENCE INTERVALS; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NORWAY; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE; TIME FACTORS;

EID: 67649306248     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.03.029     Document Type: Article

References (28)

1. Jernberg T., Stridsberg M., Venge P., and Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40 (2002) 437-445
2. Anand I.S., Fisher L.D., Chiang Y.T., Latini R., Masson S., Maggioni A.P., Glazer R.D., Tognoni G., and Cohn J.N. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003) 1278-1283
3. Sharma J.C., Ananda K., Ross I., Hill R., and Vassallo M. N-terminal pro-brain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis 15 (2006) 121-127
4. Etgen T., Baum H., Sander K., and Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 36 (2005) 270-275
5. Nakagawa K., Yamaguchi T., Seida M., Yamada S., Imae S., Tanaka Y., Yamamoto K., and Ohno K. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 19 (2005) 157-164
6. Giannakoulas G., Hatzitolios A., Karvounis H., Koliakos G., Charitandi A., Dimitroulas T., Savopoulos C., Tsirogianni E., and Louridas G. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 56 (2005) 723-730
7. Jensen J.K., Mickley H., Bak S., Korsholm L., and Kristensen S.R. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis 22 (2006) 439-444
8. Estrada V., Tellez M.J., Moya J., Fernandez-Durango R., Egido J., and Fernandez Cruz A.F. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 7 (1994) 1085-1090
9. Makikallio A.M., Makikallio T.H., Korpelainen J.T., Vuolteenaho O., Tapanainen J.M., Ylitalo K., Sotaniemi K.A., Huikuri H.V., and Myllyla V.V. Natriuretic peptides and mortality after stroke. Stroke 36 (2005) 1016-1020
10. Iltumur K., Karabulut A., Apak I., Aluclu U., Ariturk Z., and Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 151 (2006) 1122-1129
11. Yip H.K., Sun C.K., Chang L.T., Chen M.C., and Liou C.W. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. Circ J 70 (2006) 447-452
12. Banki N.M., Kopelnik A., Dae M.W., Miss J., Tung P., Lawton M.T., Drew B.J., Foster E., Smith W., Parmley W.W., and Zaroff J.G. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 112 (2005) 3314-3319
13. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Stroke 16 (1985) 885-890
14. Collin C., Wade D.T., Davies S., and Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud 10 (1988) 61-63
15. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
16. Montaner J., Perea-Gainza M., Delgado P., Ribo M., Chacon P., Rosell A., Quintana M., Palacios M.E., Molina C.A., and Alvarez-Sabin J. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39 (2008) 2280-2287
17. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H., Clopton P., Steg P.G., Westheim A., Knudsen C.W., Perez A., Kazanegra R., Herrmann H.C., and McCullough P.A. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
18. Wang T.J., Larson M.G., Levy D., Leip E.P., Benjamin E.J., Wilson P.W., Sutherland P., Omland T., and Vasan R.S. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90 (2002) 254-258
19. Vickery S., Price C.P., John R.I., Abbas N.A., Webb M.C., Kempson M.E., and Lamb E.J. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 46 (2005) 610-620
20. Rossi A., Enriquez-Sarano M., Burnett Jr. J.C., Lerman A., Abel M.D., and Seward J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
21. Omland T., Sabatine M.S., Jablonski K.A., Rice M.M., Hsia J., Wergeland R., Landaas S., Rouleau J.L., Domanski M.J., Hall C., Pfeffer M.A., and Braunwald E. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE trial. J Am Coll Cardiol 50 (2007) 205-214
22. Bibbins-Domingo K., Gupta R., Na B., Wu A.H., Schiller N.B., and Whooley M.A. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297 (2007) 169-176
23. Baggish A.L., van Kimmenade R., Bayes-Genis A., Davis M., Lainchbury J.G., Frampton C., Pinto Y., Richards M.A., and Januzzi J.L. Hemoglobin and N-terminal pro-brain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failureResults from the International Collaborative of NT-proBNP (ICON) Study. Results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta 381 (2007) 145-150
24. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., Tung R., Cameron R., Nagurney J.T., Chae C.U., Lloyd-Jones D.M., Brown D.F., Foran-Melanson S., Sluss P.M., Lee-Lewandrowski E., and Lewandrowski K.B. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
25. Wu A.H., Smith A., Wieczorek S., Mather J.F., Duncan B., White C.M., McGill C., Katten D., and Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631
26. Modrego P.J., Boned B., Berlanga J.J., and Serrano M. Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci 5 (2008) 18-23
27. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide?. How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
28. Lainchbury J.G., Troughton R.W., Frampton C.M., Yandle T.G., Hamid A., Nicholls M.G., and Richards A.M. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail 8 (2006) 532-538